Back to homepage

Infectious disease

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs

Authors: Pedro Luis Gonzalez MD, MT, Urania Rappo MD, Karthik Akinapelli MS, Jennifer S McGregor RPh, Sailaja Puttagunta MD, Michael W Dunne MD

This subgroup analysis sought to more fully characterize the demographics, baseline characteristics, safety, and efficacy of
dalbavancin in the persons who inject drugs (PWID) and non-PWID population and as a single-dose therapy versus 2-dose therapy from a previously published global trial.

More▸

How to manage Pseudomonas aeruginosa infections

Authors: Matteo Bassetti MD, PhD, Antonio Vena MD, Antony Croxatto PhD, Elda Righi MD, PhD, Benoit Guery MD, PhD

This review looks at the mechanisms associated with resistance to Pseudomonas aeruginosa, as well as antibiotic combinations and limitations of current therapies, and the potential for alternative drugs and new therapeutic options are also discussed.

More▸

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV

Authors: Milena M McLaughlin PharmD, MSc, Aimee J Guerrero BS, Andrew Merker PharmD

Reviews literature published regarding non-tenofovir antiretroviral agents causing renal adverse effects.

More▸

The latest evidence for possible HIV-1 curative strategies

Authors: Hanh Thi Pham PhD, Thibault Mesplède PhD

This review focuses on some of the current curative strategies aiming at providing a sterilizing or functional cure to HIV-1-positive individuals.

More▸

Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands

Authors: George Kassianos, Patricia Blank, Oana Falup-Pecurariu, Ernest Kuchar, Jan Kyncl, Raul Ortiz De Lejarazu, Aneta Nitsch-Osuch, Gerrit A Van Essen

In this article the authors aim to harmonise the diagnosis of seasonal influenza and the approach of European general practitioners to vaccination in order to better identify influenza outbreaks and achieve a target vaccination rate of 75% throughout Europe.

More▸